Indrayani Biotech - (Rights Entitlements (REs)) Fundamental Analysis
INDRA-RE
0.120.03 (-20.00%)
Last updated on 22 Sep, 2026 | 16:01 IST
Free Demat with Zero AMC*
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Indrayani Biotech - (Rights Entitlements (REs)) Score Card
Price
Attractive
Growth
Quality
Poor
Management
Poor
On its scorecard, Indrayani Biotech - (Rights Entitlements (REs)) reflects: Price – Attractive, Growth – , Quality – Poor, and Management – Poor. Together, these indicators provide a structured view of the company’s fundamentals.
Indrayani Biotech - (Rights Entitlements (REs)) Associated Pages
- Indrayani Biotech - (Rights Entitlements (REs))
Share Price - Indrayani Biotech - (Rights Entitlements (REs))
Share Price chart - Indrayani Biotech - (Rights Entitlements (REs))
Technical Analysis - Indrayani Biotech - (Rights Entitlements (REs))
Peer Comparison - Indrayani Biotech - (Rights Entitlements (REs))
Share Price History - Indrayani Biotech - (Rights Entitlements (REs))
Shareholding Pattern
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in INDRA-RE
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC